Other Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference September 9, 2022
Cannabis Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q at The Society for the Study of Behavioural Phenotypes (SSBP) 24th International Research Symposium September 9, 2022
Food & Beverage Mission Produce(TM) Announces Fiscal 2022 Third Quarter Financial Results September 9, 2022
Industrials AAR to announce first quarter fiscal year 2023 results on September 22, 2022 September 9, 2022
Industrials Blink Charging and UBS Asset Management Sign Agreement for Deployment of EV Charging Stations and Services September 9, 2022